DuPont De Nemours Earnings, Income Beat in Q1 By


© Reuters. DuPont De Nemours Earnings, Income Beat in Q1 – DuPont (NYSE:) De Nemours reported on Tuesday first quarter that beat analysts’ forecasts and income that topped expectations.

DuPont De Nemours introduced earnings per share of $0.91 on income of $3.98B. Analysts polled by anticipated EPS of $0.7497 on income of $3.85B.

DuPont De Nemours shares are up 10% from the start of the yr, nonetheless down 10.30% from its 52 week excessive of $87.27 set on January 12. They’re outperforming the S&P World 100 which is up 9.42% from the beginning of the yr.

DuPont De Nemours follows different main Healthcare sector earnings this month

DuPont De Nemours’s report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on income of $22.32B, in comparison with forecasts EPS of $2.34 on income of $21.98B.

Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on income of $10.46B, in comparison with forecast for EPS of $1.27 on income of $10.69B.

Keep up-to-date on all the upcoming earnings reviews by visiting’s earnings calendar

Disclaimer: Fusion Media wish to remind you that the information contained on this web site is just not essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs aren’t offered by exchanges however slightly by market makers, and so costs will not be correct and will differ from the precise market worth, which means costs are indicative and never acceptable for buying and selling functions. Due to this fact Fusion Media doesn`t bear any accountability for any buying and selling losses you may incur because of utilizing this knowledge.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or harm because of reliance on the data together with knowledge, quotes, charts and purchase/promote alerts contained inside this web site. Please be absolutely knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties potential.


Please enter your comment!
Please enter your name here